| Primary |
| Drug Use For Unknown Indication |
23.4% |
| Maternal Exposure During Pregnancy |
18.8% |
| Anaesthesia |
15.6% |
| Drug Exposure During Pregnancy |
6.3% |
| Preoperative Care |
6.3% |
| General Anaesthesia |
4.7% |
| Induction Of Anaesthesia |
4.7% |
| Epidural Anaesthesia |
3.1% |
| Prophylaxis |
3.1% |
| Stent Placement |
3.1% |
| Analgesic Intervention Supportive Therapy |
1.6% |
| Antibiotic Prophylaxis |
1.6% |
| Hormone Replacement Therapy |
1.6% |
| Labour Pain |
1.6% |
| Postoperative Care |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Rheumatoid Arthritis |
1.6% |
|
| Bradycardia |
15.0% |
| Cardiac Arrest |
10.0% |
| Pancreatitis Acute |
10.0% |
| Viith Nerve Paralysis |
10.0% |
| Bradycardia Foetal |
5.0% |
| Foetal Arrhythmia |
5.0% |
| Foetal Exposure During Delivery |
5.0% |
| Maternal Drugs Affecting Foetus |
5.0% |
| Obstetric Procedure Complication |
5.0% |
| Pain |
5.0% |
| Procedural Complication |
5.0% |
| Pruritus |
5.0% |
| Renal Failure Acute |
5.0% |
| Sensory Disturbance |
5.0% |
| Vacuum Extractor Delivery |
5.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.2% |
| Anaesthesia |
19.8% |
| Product Used For Unknown Indication |
13.9% |
| Induction Of Anaesthesia |
10.9% |
| General Anaesthesia |
8.3% |
| Premedication |
4.2% |
| Hysterectomy |
3.1% |
| Scoliosis Surgery |
2.2% |
| Spinal Anaesthesia |
1.8% |
| Antibiotic Prophylaxis |
1.8% |
| Sedation |
1.8% |
| Analgesic Therapy |
1.6% |
| Analgesic Effect |
1.6% |
| Pain |
1.6% |
| Epidural Anaesthesia |
1.4% |
| Hypotension |
1.4% |
| Anaesthesia Procedure |
1.2% |
| Cystoscopy |
1.2% |
| Ureteroscopy |
1.2% |
| Maintenance Of Anaesthesia |
1.0% |
|
| Anaphylactic Shock |
21.7% |
| Hypotension |
8.5% |
| Spinal Cord Ischaemia |
5.3% |
| Toxic Skin Eruption |
5.3% |
| Urticaria |
5.3% |
| Overdose |
4.8% |
| Renal Failure Acute |
4.8% |
| Bronchospasm |
4.2% |
| Cauda Equina Syndrome |
4.2% |
| Shock |
4.2% |
| Angioedema |
3.7% |
| Circulatory Collapse |
3.7% |
| Erythema |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Cardiac Arrest |
3.2% |
| Transaminases Increased |
3.2% |
| Cytolytic Hepatitis |
2.6% |
| Haemodynamic Instability |
2.6% |
| Hepatitis |
2.6% |
| Tachycardia |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.7% |
| Drug Use For Unknown Indication |
10.5% |
| Anaesthesia |
10.2% |
| Sedation |
6.8% |
| Hypertension |
4.4% |
| Coronary Artery Bypass |
4.3% |
| Sepsis |
4.3% |
| Infection |
4.1% |
| Prophylaxis |
3.5% |
| Induction Of Anaesthesia |
3.1% |
| Constipation |
2.9% |
| General Anaesthesia |
2.6% |
| Pain |
2.4% |
| Analgesic Therapy |
2.1% |
| Maintenance Of Anaesthesia |
2.0% |
| Medical Diet |
1.8% |
| Peritonitis |
1.8% |
| Septic Shock |
1.6% |
| Premedication |
1.5% |
| Antibiotic Prophylaxis |
1.5% |
|
| Injury |
7.5% |
| Unevaluable Event |
7.5% |
| Fear |
6.4% |
| Pyrexia |
6.4% |
| Tachycardia |
6.4% |
| Renal Failure |
5.8% |
| Ureterostomy Site Discomfort |
5.8% |
| Ventricular Tachycardia |
5.8% |
| Anaphylactic Shock |
5.2% |
| Anhedonia |
5.2% |
| Bradycardia |
5.2% |
| Anxiety |
4.0% |
| Pain |
4.0% |
| Respiratory Failure |
4.0% |
| Vomiting |
4.0% |
| Cerebrovascular Accident |
3.5% |
| Renal Injury |
3.5% |
| Septic Shock |
3.5% |
| Stress |
3.5% |
| Bronchospasm |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
72.7% |
| Cancer Pain |
18.2% |
| Renal Cancer Metastatic |
9.1% |
|
| Shock |
66.7% |
| General Physical Health Deterioration |
33.3% |
|
